The present study is a feasibility study to assess the safety and efficacy of wireless capsule endoscope and compare the data obtained with those obtained by using a conventional esophagogastroduodenoscopy. The product was developed and manufacture in China.(the NaviCam. AKC-1.China)
Study Type
INTERVENTIONAL
Allocation
RANDOMIZED
Purpose
DIAGNOSTIC
Masking
TRIPLE
Enrollment
80
Departement of Gastroenterology, Nanfang Hospital, Southern Medical University
Guangzhou, Guangdong, China
RECRUITINGthe percentage of complete visualization of anatomic landmarks
the percentage of patients in whom there was complete visualization of the gastric surface in the antrum, body, and fundus and identification of the cardia and pylorus
Time frame: 2 year
examination time and the percentage of abnormal finding
examination time and the percentage of abnormal findings seen on gastroscopy that were reproducible by capsule endoscopy
Time frame: 2 year
adverse effect
any discomfort like chest pain, nausea will be documented. capsule retention(defined as not extrusion in 14 days)will be documented.
Time frame: 2 year
Acceptability
Acceptability to patients was assessed by means of a questionnaire, with ratings on a scale of 0 to 10 and examination chosen for next time. completed in the recovery room immediately after capsule examination.
Time frame: 2 year
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.